Corbus Pharmaceuticals Holdings (CRBP) Financials

CRBP Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 28.3 million 35.2 million
2023-09-30 36.3 million 36.0 million
2023-06-30 43.7 million 34.2 million
2023-03-31 51.6 million 35.2 million

CRBP Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -6.0 million 799177
2023-09-30 -7.2 million 821223
2023-06-30 -7.8 million 823375
2023-03-31 -15.1 million 1.0 million

CRBP Net Income

No data available :(

CRBP Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 21.1 million - 4.7 million
2023-09-30 28.7 million - 5.0 million
2023-06-30 36.6 million 11.3 million 5.3 million
2023-03-31 44.2 million 14.0 million 5.7 million

CRBP Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 4.4 million
2023-09-30 4.4 million
2023-06-30 4.3 million
2023-03-31 4.2 million

CRBP Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 7.0 million 3.1 million 147978
2023-09-30 - 6.6 million 2.9 million -
2023-06-30 - 4.2 million 3.9 million -
2023-03-31 - 13.4 million 3.9 million -

CRBP Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 147978
2023-09-30 - 152809
2023-06-30 - 158343
2023-03-31 - 363740

CRBP

Price: $38.77

52 week price:
3.03
49.87

Earnings Per Share: -10.31 USD

P/E Ratio: -2.35

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 1.8 million

Ebitda: -6.8 million

Market Capitalization: 419.4 million

Links: